Matrix Laboratories has manufacturing facilities at four locations in and around Hyderabad and Visakhapatnam, India, manufacturing a wide range of Active Pharmaceutical Ingredients.
The company's Solid Oral Dosage Forms facility is located near Nashik, about 150 km from Mumbai. All the manufacturing facilities in India have been designed to meet the requirements of Drug Regulatory Agencies. All our facilities are US-FDA approved. The facilities also have ISO 9000, ISO 14000 Certifications.
The Matrix Laboratories Unit III site is located near the town of Jeedimetla, approximately 17 kilometres north-east of Hyderabad, in the state of Andhra Pradesh. The site comprises five separate manufacturing buildings; each dedicated to the manufacture of active pharmaceutical ingredients, and occupies an area of approximately 3.7 hectares
For more information on Matrix Laboratories Limited Unit 3 please follow link:
About the Audit
The audit of the Matrix Laboratories Limited Unit 3 site was performed on 4 - 5 December 2007. The Report includes photographs and is 33 pages long, excluding appendices. Including appendices, the Report is 76 pages long.
The Audit Report provides information on the site facilities and covers a wide range of materials, including; Aripiprazole, Armodafinil, Atorvastatin, Carvedilol, Candesartan Cilexetil, Carvedilol Phosphate, Celecoxib, Ciprofloxacin Hydrochloride, Citalpram Hydrobromide, Citalpram Hydrochloride, Duloxetine Hydrochloride, Efavirenz, Escitalopram Oxalate, Esomprezole Magnesium, Eszopiclone, Gabapentin, Gatifloxacin, Irbesartan, Itraconazole, Levofloxacin Hemihydrate, Lopinavir, Mirtazapine Anhydrous, Mirtzapine Hemihydrate, Modafinil, Montelukast Sodium, Moxifloxacin Hydrochloride, Norfloxacin, Olanzapine, Olmesartan Medoxomil, Pantoprazole Sodium, Quetiapine Fumarate, Rabeprazole Sodium, Sertraline Hydrochloride, Sibutramine Hydrochloride, Simvastatin, Tadalafil, Telmisartan, Terazosin Hydrochloride, Valsartan, Venlafaxine Hydrochloride, Zolpidem Tartarate and Zonisamide.